The molecular mechanisms underlying miR-181-mediated effect in malignant progression of breast cancer have been elucidated and associated with a novel target, the tumor suppressor SPRY4 (Protein sprouty homolog 4) [56]. This evidence concerns the gene SPRY4 and breast cancer.